Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Colorectal cancer and Breast cancer, with related work in Inflammasome, Wnt signaling pathway, KEGG. Notable publications include 'Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer', 'Role of the nucleotide‐binding domain‐like receptor protein 3 inflammasome in acute kidney injury', and 'Hsa_circ_0001445 works as a cancer suppressor via miR‐576‐5p/SFRP1 axis regulation in ovarian cancer'.
Retagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
Hsa_circ_0001445 works as a cancer suppressor via miR‐576‐5p/SFRP1 axis regulation in ovarian cancer
iUMRG: multi-layered network-guided propagation modeling for the inference of susceptibility genes and potential drugs against uveal melanoma
Aspirin induced long non coding RNA suppresses colon cancer growth
Correction: Comparison of the expression and function of Lin28A and Lin28B in colon cancer
Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer
miR-203a controls keratinocyte proliferation and differentiation via targeting the stemness-associated factor ΔNp63 and establishing a regulatory circuit with SNAI2
Role of the nucleotide‐binding domain‐like receptor protein 3 inflammasome in acute kidney injury